{"id":10437,"date":"2019-10-04T14:14:30","date_gmt":"2019-10-04T12:14:30","guid":{"rendered":"http:\/\/k1nytt.w.uib.no\/?p=10437"},"modified":"2019-10-04T14:14:30","modified_gmt":"2019-10-04T12:14:30","slug":"phd-hjornet-24","status":"publish","type":"post","link":"https:\/\/k1nytt.w.uib.no\/en\/2019\/10\/04\/phd-hjornet-24\/","title":{"rendered":"PhD-hj\u00f8rnet"},"content":{"rendered":"

Nye doktorgrader<\/h4>\n

KARI BRITT HAGEN<\/a> disputerte 23. september 2019 med sin avhandling \u00abBREAST CANCER. Adherence to Adjuvant Endocrine Therapy in Western Norwegian Patients\u00bb. VI gratulerer med gjennomf\u00f8rt disputas!<\/p>\n

EIVIND KOLSTAD<\/a> disputerte 27. september 2019 med sin avhandling \u201cOverweight and eating disorders in people with epilepsy\u201d. VI gratulerer med gjennomf\u00f8rt disputas!<\/p>\n

\n

Kommende disputaser<\/h4>\n

RAGNHILD EIDE SKOGSETH<\/strong>
\nKandidaten utg\u00e5r fra Klinisk institutt 1.
\nHovedveileder: Professor Dag \u00c5rsland
\nMedveiledere: Professor Nils Erik Gilhus og professor Tormod Fladby<\/p>\n

Pr\u00f8veforelesning: Onsdag 16. oktober 2019 kl. 10.15
\n<\/strong>Sted: Auditorium, SMU (Haraldsplass), Ulriksdal 8
\nOppgitt emne: \u201cHow may biomarker studies in dementia help to determine possible treatments for the disorder?\u201d<\/p>\n

Disputas: Onsdag 16. oktober 2019 kl. 12.15<\/strong>
\nSted: Auditorium, SMU (Haraldsplass), Ulriksdal 8
\nAvhandlingens tittel: \u201cBiomarker and pathology studies in neurodegenerative cognitive impairment\u201d<\/p>\n

1. opponent: Clinical Research Fellow Alison Yarnall, Newcastle University
\n2. opponent: Postdoctoral Fellow Leiv Otto Watne, Universitetet i Oslo
\n3. medlem av komiteen: Professor Mai Tone L\u00f8nnebakken, Universitetet i Bergen<\/p>\n

Disputasen blir ledet av professor emerita Liv Inger Strand.
\n\u00c5pent for alle interesserte.<\/p>","protected":false},"excerpt":{"rendered":"

Nye doktorgrader KARI BRITT HAGEN disputerte 23. september 2019 med sin avhandling \u00abBREAST CANCER. Adherence to Adjuvant Endocrine Therapy in Western Norwegian Patients\u00bb. VI gratulerer med gjennomf\u00f8rt disputas! EIVIND KOLSTAD disputerte 27. september 2019 med sin avhandling \u201cOverweight and eating…<\/p>\n

Read more →<\/a><\/p>","protected":false},"author":4402,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10437","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/10437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/users\/4402"}],"replies":[{"embeddable":true,"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=10437"}],"version-history":[{"count":7,"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/10437\/revisions"}],"predecessor-version":[{"id":10483,"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/10437\/revisions\/10483"}],"wp:attachment":[{"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=10437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=10437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k1nytt.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=10437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}